Abstract:Bufadienolides are a class of steroids with a distinctive α-pyrone ring at C17, mostly produced by toads and consisting of over 100 orthologues. They exhibit potent cardiotonic and antitumor activities and are active ingredients of the traditional Chinese medicine Chansu and Cinobufacini. Direct extraction from toads is costly, and chemical synthesis is difficult, limiting the accessibility of active bufadienolides with diverse modifications and trace content. In this work, based on the transcriptome and genome analyses, using a yeast-based screening platform, we obtained eight cytochrome P450 (CYP) enzymes from toads, which catalyze the hydroxylation of bufalin and resibufogenin at different sites. Moreover, a reported fungal CYP enzyme Sth10 was found functioning in the modification of bufalin and resibufogenin at multiple sites. A total of 15 bufadienolides were produced and structurally identified, of which six were first discovered. All of the compounds were effective in inhibiting the proliferation of tumor cells, especially 19-hydroxy-bufalin (2) and 1β-hydroxy-bufalin (3), which were generated from bufalin hydroxylation catalyzed by CYP46A35. The catalytic efficiency of CYP46A35 was improved about six times and its substrate diversity was expanded to progesterone and testosterone, the common precursors for steroid drugs, achieving their efficient and site-specific hydroxylation. These findings elucidate the key modification process in the synthesis of bufadienolides by toads and provide an effective way for the synthesis of unavailable bufadienolides with site-specific modification and active potentials.

Substrate specificity for the 12beta-hydroxylation of bufadienolides by Alternaria alternata.

Specific 12Β-Hydroxylation of Cinobufagin by Filamentous Fungi

Microbial Hydroxylation of Bufalin by Cunninghamella Blakesleana and Mucor Spinosus.

Highly selective isomerization and dehydrogenation of three major bufadienolides at 3-OH by Fusarium solani

Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships.

Hydroxylation of Flavanones by Cytochrome P450 105D7 from Streptomyces Avermitilis

New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus

A New Bufadienolide Obtained from the Biotransformation of Cinobufagin Byalternaria Alternata

Microbial Transformation of Bufotalin by Alternaria Alternata As 3.4578

Biotransformation of arenobufagin and cinobufotalin by Alternaria alternata

Metabolites Profiling of 10 Bufadienolides in Human Liver Microsomes and Their Cytotoxicity Variation in HepG2 Cell.

Cytochrome P450 Mining for Bufadienolide Diversification

Microbial Transformation of Three Bufadienolides by Nocardia Sp. and Some Insight for the Cytotoxic Structure–activity Relationship (SAR)

Microbial hydroxylation of cinobufagin by Mucor spinosus.

Biotransformation of Cinobufagin by Cell Suspension Cultures of Catharanthus Roseus and Platycodon Grandiflorum

Tunable Toxicity of Bufadienolides is Regulated Through a Configuration Inversion Catalyzed by a Short-Chain Dehydrogenase/Reductase

Microbial transformation of three bufadienolides by Penicillium aurantigriseum and its application for metabolite identification in rat

7α and 7β Hydroxylation of Dehydroepiandrosterone by Gibberella sp. and Absidia Coerulea Biotransformation

Glucosylation of Cinobufagin by Cultured Suspension Cells of Catharanthus Roseus

Microbial transformation of cinobufagin by Syncephalastrum racemosum.

Selective dehydrogenation of resibufogenin and cinobufagin at 3-OH by Pseudomonas aeruginosa